In the same way Pathway Commons was successful at combining many molecular pathway and interaction database, BEL has the potential to serve as a semantic integration platform through which knowledge and data across scales can be integrated and analyzed. BEL has already been used to reason over the previously untapped sources of chemogenomic and chemical genetic information 1 and can be extended further into the realm of disease-disease, disease-protein, disease-chemical, and chemical-chemical networks.



Emon, M. A. E. K., et al. (2017). Using Drugs as Molecular Probes: A Computational Chemical Biology Approach in Neurodegenerative Diseases. Journal of Alzheimer’s Disease, 56(2), 677–686.